ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 302991 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 302991; 2) Community: the network communities that were significantly associated with the response to NSC 302991; 3) Molecule: the relationships between components within communities and NSC 302991; 4) MDR: the compounds that were significantly associated with the NSC 302991.

NSC Compound Enrichment Correlation
NSC 639517 Cyclopentanone, 2-[(4-chlorophenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.00725424828633677 0.18318892
NSC 668257 2,4(1H,3H)-Pyrimidinedione, 1-[[2-(4-chlorophenyl)- tetrahydro-4-methylene-5-oxo-2-furanyl]methyl]-5-methyl- 0.00725424828633677 -0.025607397
NSC 683856 Null 0.0072542482863368 0.085411062
NSC 698048 Null 0.0072542482863368 0.10192835
NSC 122060 Ethanesulfonic acid, compd. with N-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy]propyl]carbamoyl]metanilyl fluoride (1:1) (8CI) (MF2) 0.00725424828633685 0.25520042
NSC 105014 Cladribine 0.00741876119839022 0.5692097
NSC 619030 Analog of CC-1065 0.00741876119839028 0.65054873
NSC 641454 3'-O-(Dimethylaminoethylcarbonyl)-(Z)-combretastatin A-4 0.00741876119839028 0.29333092
NSC 697286 LY 294002 0.00741876119839028 -0.08956706
NSC 700363 Liposomal Annamycin 0.00741876119839028 0.58082369
Total:45  Current:5    [First] [Prev] [Next] [Last]